BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Rosemont Pharmaceuticals Ltd. (Acquired By Bio-Technology General Corp.) 

Yorkdale Industrial Park; Rosemont House
Braithwaite Street
Leeds    LS11 9XE  United Kingdom
Phone: 44-113-2441400 Fax: 44-113-2460738


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical






 Company News
Perrigo Company (PRGO) Buys Rosemont Pharmaceuticals Ltd. (BTGC) for $283 Million 2/11/2013 7:18:12 AM    More...
Rosemont Pharmaceuticals Ltd. (BTGC) Put Up for Sale With £200 Million Price Tag 9/25/2012 8:11:45 AM    More...
Savient Pharmaceuticals, Inc. (SVNT) Completes Sale Of Rosemont Pharmaceuticals Ltd. (BTGC) Subsidiary For $176 Million 8/4/2006 1:35:16 PM    More...
Savient Pharmaceuticals, Inc. (SVNT) Announces Exploration Of Strategic Alternatives For Rosemont Pharmaceuticals Ltd. (BTGC) Subsidiary Including Potential Spin Out Or Sale Of Business 2/17/2006 11:57:43 AM    More...
Savient Pharmaceuticals, Inc. (SVNT) Submits New Drug Application For Soltamox To The U.S. FDA 10/19/2005 5:11:56 PM    More...
Savient Pharmaceuticals, Inc. (BTGC) Announces New Strategic Direction To Focus On Product Development; Company To Focus Resources On Clinical Development Of Its Two Phase II Products, Prosaptide And Puricase 10/19/2005 5:09:00 PM    More...